help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuo, H.
Right arrow Articles by Samoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuo, H.
Right arrow Articles by Samoto, T.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 1 293-299
Copyright © 1997 by The Endocrine Society

Reproductive Endocrinology

Increased Expression of Bcl-2 Protein in Human Uterine Leiomyoma and Its Up-Regulation by Progesterone1

Hiroya Matsuo, Takeshi Maruo and Takashi Samoto

Department of Obstetrics and Gynecology, Kobe University School of Medicine, Kobe, Japan

Address all correspondence and requests for reprints to: Takeshi Maruo, M.D., Department of Obstetrics and Gynecology, Kobe University School of Medicine, 7–5-1 Kusunoki-cho, Chuo-ku, Kobe 650, Japan.

Uterine leiomyoma is the most common benign smooth muscle cell tumor of the myometrium. Although Bcl-2 protein is known to be an apoptosis-inhibiting gene product and to prevent apoptotic cell death in a variety of cells, there are no published data regarding whether human leiomyomas express Bcl-2 protein. In the present study, we examined the expression of Bcl-2 protein in leiomyomas in comparison with that in the normal myometrium using an immunohistochemical method and immunoblot analysis with a monoclonal antibody to human Bcl-2 protein. Furthermore, we investigated whether sex steroid hormones could influence the levels of Bcl-2 protein expression in leiomyoma cells cultured in vitro under serum-free, phenol red-free conditions. Immunohistochemical staining for Bcl-2 protein was prominent in leiomyoma cells, but was scarcely present in normal myometrial smooth muscle cells. The expression of Bcl-2 protein in leiomyoma cells was most abundant in the secretory, progesterone-dominated, phase of the menstrual cycle, but was less abundant in the proliferative phase of the menstrual cycle. Western blot analyses of leiomyoma and myometrium tissue extracts revealed that Bcl-2 protein, with a molecular mass estimated at approximately 26 kDa, was abundantly present in leiomyoma tissue extracts, but was undetectable in normal myometrial tissue extracts. In monolayer cultures of uterine leiomyoma cells under a serum-free condition, the addition of progesterone (100 ng/mL) resulted in a striking increase in Bcl-2 protein expression in the cultured leiomyoma cells relative to that in control cultures, whereas the addition of 17ß-estradiol (10 ng/mL) resulted in a reduction in Bcl-2 protein expression in the cells. The concentrations of sex steroids used were within the physiological tissue concentrations found in leiomyomas and myometrium. The present results suggest that the abundant expression of Bcl-2 protein may have a molecular basis characteristic of leiomyomas in the human uterus and that progesterone may play a vital role in the enhanced expression of Bcl-2 protein in human uterine leiomyoma cells.




This article has been cited by other articles:


Home page
 Hum ReprodHome page
A. Morikawa, N. Ohara, Q. Xu, K. Nakabayashi, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer
Hum. Reprod., April 1, 2008; 23(4): 944 - 951.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
Q. Xu, N. Ohara, J. Liu, M. Amano, R. Sitruk-Ware, S. Yoshida, and T. Maruo
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells
Mol. Hum. Reprod., March 1, 2008; 14(3): 181 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
N. Ohara, A. Morikawa, Wei Chen, Jiayin Wang, D. A. DeManno, K. Chwalisz, and T. Maruo
Comparative Effects of SPRM Asoprisnil (J867) on Proliferation, Apoptosis, and the Expression of Growth Factors in Cultured Uterine Leiomyoma Cells and Normal Myometrial Cells
Reproductive Sciences, December 1, 2007; 14(8_suppl): 20 - 27.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
M. A. Behera, L. Feng, B. Yonish, W. Catherino, S.-H. Jung, and P. C. Leppert
Thrombospondin-1 and Thrombospondin-2 mRNA and TSP-1 and TSP-2 Protein Expression in Uterine Fibroids and Correlation to the Genes COL1A1 and COL3A1 and to the Collagen Cross-link Hydroxyproline
Reproductive Sciences, December 1, 2007; 14(8_suppl): 63 - 76.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Yin, Z. Lin, Y.-H. Cheng, E. E. Marsh, H. Utsunomiya, H. Ishikawa, Q. Xue, S. Reierstad, J. Innes, S. Thung, et al.
Progesterone Receptor Regulates Bcl-2 Gene Expression through Direct Binding to Its Promoter Region in Uterine Leiomyoma Cells
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4459 - 4466.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. H. Hassan, S. A. Salama, H. M. M. Arafa, F. M. A. Hamada, and A. Al-Hendy
Adenovirus-Mediated Delivery of a Dominant-Negative Estrogen Receptor Gene in Uterine Leiomyoma Cells Abrogates Estrogen- and Progesterone-Regulated Gene Expression
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3949 - 3957.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Q. Xu, N. Ohara, J. Liu, K. Nakabayashi, D. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1002 - E1011.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Liu, H. Matsuo, Q. Xu, W. Chen, J. Wang, and T. Maruo
Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro
Hum. Reprod., May 1, 2007; 22(5): 1253 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Sasaki, N. Ohara, Q. Xu, J. Wang, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
A Novel Selective Progesterone Receptor Modulator Asoprisnil Activates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Signaling Pathway in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 616 - 623.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
S. A. Salama, A. B. Nasr, R. K. Dubey, and A. Al-Hendy
Estrogen Metabolite 2-Methoxyestradiol Induces Apoptosis and Inhibits Cell Proliferation and Collagen Production in Rat and Human Leiomyoma Cells: A Potential Medicinal Treatment for Uterine Fibroids
Reproductive Sciences, December 1, 2006; 13(8): 542 - 550.
[Abstract] [PDF]

Home page
 Poult. Sci.Home page
W. Berry, A. Doernte, M. Conner, M. Barnes, and S. Oates
Spontaneously occurring fibroid tumors of the laying hen oviduct.
Poult. Sci., November 1, 2006; 85(11): 1969 - 1974.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Q. Xu, N. Ohara, W. Chen, J. Liu, H. Sasaki, A. Morikawa, R. Sitruk-Ware, E. D.B. Johansson, and T. Maruo
Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells
Hum. Reprod., September 1, 2006; 21(9): 2408 - 2416.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Wang, N. Ohara, Z. Wang, W. Chen, A. Morikawa, H. Sasaki, D. A. DeManno, K. Chwalisz, and T. Maruo
A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells
Hum. Reprod., July 1, 2006; 21(7): 1869 - 1877.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. A. Williams, A. Verhovez, A. Milan, F. Veglio, and P. Mulatero
Protective Effect of Spironolactone on Endothelial Cell Apoptosis
Endocrinology, May 1, 2006; 147(5): 2496 - 2505.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Chen, N. Ohara, J. Wang, Q. Xu, J. Liu, A. Morikawa, H. Sasaki, S. Yoshida, D. A. Demanno, K. Chwalisz, et al.
A Novel Selective Progesterone Receptor Modulator Asoprisnil (J867) Inhibits Proliferation and Induces Apoptosis in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1296 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
Endocr. Rev., May 1, 2005; 26(3): 423 - 438.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Q. Xu, S. Takekida, N. Ohara, W. Chen, R. Sitruk-Ware, E. D. B. Johansson, and T. Maruo
Progesterone Receptor Modulator CDB-2914 Down-Regulates Proliferative Cell Nuclear Antigen and Bcl-2 Protein Expression and Up-Regulates Caspase-3 and Poly(Adenosine 5'-Diphosphate-ribose) Polymerase Expression in Cultured Human Uterine Leiomyoma Cells
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 953 - 961.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Shushan, N. Rojansky, N. Laufer, B. Y. Klein, Z. Shlomai, R. Levitzki, Z. Hartzstark, and H. Ben-Bassat
The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth
Hum. Reprod., September 1, 2004; 19(9): 1957 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
T. Maruo, N. Ohara, J. Wang, and H. Matsuo
Sex steroidal regulation of uterine leiomyoma growth and apoptosis
Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
K. Bodner, B. Bodner-Adler, O. Kimberger, K. Czerwenka, and K. Mayerhofer
Bcl-2 Receptor Expression in Patients With Uterine Smooth Muscle Tumors: An Immunohistochemical Analysis Comparing Leiomyoma, Uterine Smooth Muscle Tumor of Uncertain Malignant Potential, and Leiomyosarcoma
Reproductive Sciences, April 1, 2004; 11(3): 187 - 191.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
T. Yamada, S. Nakago, O. Kurachi, J. Wang, S. Takekida, H. Matsuo, and T. Maruo
Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells
Hum. Reprod., April 1, 2004; 19(4): 815 - 821.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S.-C. Huang, M.-J. Tang, K.-F. Hsu, Y.-M. Cheng, and C.-Y. Chou
Fas and Its Ligand, Caspases, and Bcl-2 Expression in Gonadotropin-Releasing Hormone Agonist-Treated Uterine Leiomyoma
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4580 - 4586.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. Gao, H. Matsuo, S. Nakago, O. Kurachi, and T. Maruo
p53 Tumor Suppressor Protein Content in Human Uterine Leiomyomas and Its Down-Regulation by 17{beta}-Estradiol
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3915 - 3920.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
C. L. Walker
Role of Hormonal and Reproductive Factors in the Etiology and Treatment of Uterine Leiomyoma
Recent Prog. Horm. Res., January 1, 2002; 57(1): 277 - 294.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. Gao, H. Matsuo, Y. Wang, S. Nakago, and T. Maruo
Up-Regulation by IGF-I of Proliferating Cell Nuclear Antigen and Bcl-2 Protein Expression in Human Uterine Leiomyoma Cells
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5593 - 5599.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Maruo, J.B. Laoag-Fernandez, P. Pakarinen, H. Murakoshi, I.M. Spitz, and E. Johansson
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium
Hum. Reprod., October 1, 2001; 16(10): 2103 - 2108.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. Rodriguez-Sallaberry, F. A. Simmen, and R. C.M. Simmen
Polyamine- and Insulin-Like Growth Factor-I-Mediated Proliferation of Porcine Uterine Endometrial Cells: A Potential Role for Spermidine/Spermine N1-Acetyltransferase During Peri-Implantation
Biol Reprod, August 1, 2001; 65(2): 587 - 594.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. Kurachi, H. Matsuo, T. Samoto, and T. Maruo
Tumor Necrosis Factor-{{alpha}} Expression in Human Uterine Leiomyoma and Its Down-Regulation by Progesterone
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2275 - 2280.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
K. D. Burroughs, R. Fuchs-Young, B. Davis, and C. L. Walker
Altered Hormonal Responsiveness of Proliferation and Apoptosis During Myometrial Maturation and the Development of Uterine Leiomyomas in the Rat
Biol Reprod, November 1, 2000; 63(5): 1322 - 1330.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Benassayag, M. J. Leroy, V. Rigourd, B. Robert, J. C. Honore, T. M. Mignot, M. C. Vacher-Lavenu, C. Chapron, and F. Ferre
Estrogen receptors (ERalpha /ERbeta ) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1112 - E1118.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Shimomura, H. Matsuo, T. Samoto, and T. Maruo
Up-Regulation by Progesterone of Proliferating Cell Nuclear Antigen and Epidermal Growth Factor Expression in Human Uterine Leiomyoma
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2192 - 2198.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
X.-J. Tao, K. I. Tilly, D. V. Maravei, J. L. Shifren, S. Krajewski, J. C. Reed, J. L. Tilly, and K. B. Isaacson
Differential Expression of Members of the bcl-2 Gene Family in Proliferative and Secretory Human Endometrium: Glandular Epithelial Cell Apoptosis Is Associated with Increased Expression of bax
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2738 - 2746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society